CencoraNYSE: COR

Cencora (COR) shares declined on Jun 27, following an unfavorable ruling from the Supreme Court related to a previously settled litigation. Here we discuss the key factors that likely led to the decline.

VANCOUVER, BC / ACCESSWIRE / June 27, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF)(WKN:A116E1) ("Camino" or the "Company") is pleased to announce that it has been granted exclusivity to complete due diligence and negotiate documentation by August 31, 2024, to acquire (the "Proposed Acquisition") the Puquios Project, a construction-ready copper project located in Chile, approximately 130 km northeast of La Serena, Coquimbo region (the "Project"). Camino has signed a non-binding Letter-of-Intent ("LOI") dated May 29, 2024, to acquire the Project in a 50:50 joint venture with Nittetsu Mining Co., Ltd.

Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

COR shares have advanced 13% since my last publication, adding conviction to the long-term thesis. The company has exceptional economic characteristics with abnormally high ROICs and negative working capital benefits. I have updated my price objectives to $270-$285 with a long-term intrinsic valuation of over $360 per share.

Cencora (COR) gaining traction from the robust U.S. Healthcare Solutions segment raises optimism about the stock.

VANCOUVER, BC / ACCESSWIRE / June 5, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF)(WKN:A116E1) ("Camino" or the "Company") is pleased to announce the receipt of the third option payment of CAD$1.5 million from exploration partner Nittetsu Mining CO., Ltd. ("Nittetsu") to support the next phase of exploration of Camino's Los Chapitos Copper Project ("Los Chapitos" or the "Project") in Peru.

Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Cencora has agreed to buy about $400 million in stock back from Walgreens Boots Alliance, the second time the pharmacy chain has reduced its stake in the company this year as it looks to free up cash to pare down debt.